Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
<div>Novavax's vaccine has shown 89 per cent efficacy in UK trials. The government has bought 60 million doses of the jab, and it's expected that production will begin in Teesside later this year. But, as the EU's rollout languishes and their row with AstraZeneca escalates, should Britain consider giving away its vaccines? Katy Balls speaks to James Forsyth and Fraser Nelson.</div><p>Become a <em>Spectator </em>subscriber today to access this podcast without adverts. Go to <a href="https://www.spectator.co.uk/follow-your-podcasts/" rel="noopener noreferrer" target="_blank">spectator.co.uk/adfree</a> to find out more.</p><br><p>For more <em>Spectator</em> podcasts, go to <a href="https://www.spectator.co.uk/podcasts/" rel="noopener noreferrer" target="_blank">spectator.co.uk/podcasts</a>.</p><br><p>Contact us: [email protected]</p>
<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>